236 related articles for article (PubMed ID: 24261365)
1. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
2. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
Rosenkrantz AB; Haghighi M; Horn J; Naik M; Hardie AD; Somberg MB; Melamed J; Xiao GQ; Huang WC; Taouli B
AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
5. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
Akita H; Jinzaki M; Kikuchi E; Sugiura H; Akita A; Mikami S; Kuribayashi S
AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
[TBL] [Abstract][Full Text] [Related]
6. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
7. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
8. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
[TBL] [Abstract][Full Text] [Related]
9. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
Rheinheimer S; Stieltjes B; Schneider F; Simon D; Pahernik S; Kauczor HU; Hallscheidt P
Eur J Radiol; 2012 Mar; 81(3):e310-6. PubMed ID: 22104090
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
Wang HJ; Pui MH; Guo Y; Li SR; Guan J; Zhang XL; Cai HS
AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
[TBL] [Abstract][Full Text] [Related]
13. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
[TBL] [Abstract][Full Text] [Related]
15. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.
Maruyama M; Yoshizako T; Uchida K; Araki H; Tamaki Y; Ishikawa N; Shiina H; Kitagaki H
Acta Radiol; 2015 Feb; 56(2):250-6. PubMed ID: 24518687
[TBL] [Abstract][Full Text] [Related]
16. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A
Eur J Radiol; 2013 Nov; 82(11):1870-6. PubMed ID: 23932396
[TBL] [Abstract][Full Text] [Related]
17. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
20. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
